Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Glen Rock, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
RespireRx Pharmaceuticals Inc. has filed 926 SEC EDGAR filings since 30 Oct 1995

SEC filing history

Showing 51-75 of 517 matching filings.

Per page
25
Current page
3
253G2 File 024-11602

253G2 filing

Filing date
08 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
253G2 File 024-11602

253G2 filing

Filing date
17 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
253G2 File 024-11602

253G2 filing

Filing date
10 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
253G2 File 024-11602

253G2 filing

Filing date
03 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
253G2 File 024-11602

253G2 filing

Filing date
14 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
253G2 File 024-11602

253G2 filing

Filing date
14 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
253G3 File 024-11602

253G3 filing

Filing date
14 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
QUALIF File 024-11602

QUALIF filing

Filing date
13 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
1-A/A File 024-11602

1-A/A filing

Filing date
01 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-16467

10-Q filing

Filing date
15 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
1-A/A File 024-11602

1-A/A filing

Filing date
12 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .